{
    "laboratory_examinations": [
        {
            "procedure_name": "Serum Chemistry",
            "date": "Not specified",
            "findings": {
                "sodium": "133 mmol/L",
                "chloride": "97 mmol/L",
                "creatinine": "1.4 mg/dL (124 μmol/L)",
                "total_bilirubin": "1.4 mg/dL (24 μmol/L)",
                "white_cell_count": "22,500 per cubic mm, with 87% neutrophils and 5% lymphocytes",
                "hematocrit": "44.8%",
                "platelet_count": "200,000 per cubic mm"
            },
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Blood Cultures",
            "date": "Day 1 of hospitalization",
            "findings": {
                "initial_culture": "Gram-negative rods in a single anaerobic bottle",
                "subsequent_culture": "No growth by day 8"
            },
            "changes_over_time": "The organism from blood culture was identified as Pseudomonas luteola on day 6."
        },
        {
            "procedure_name": "Serum Chemistry",
            "date": "Not specified (but on or after transfer to another hospital)",
            "findings": {
                "creatinine": "0.7 mg/dL (62 μmol/L)",
                "total_bilirubin": "0.7 mg/dL (12 μmol/L)",
                "white_cell_count": "21,600 per cubic mm",
                "hematocrit": "35.0%",
                "platelet_count": "381,000 per cubic mm"
            },
            "changes_over_time": "Creatinine levels decreased from 1.4 mg/dL to 0.7 mg/dL; bilirubin levels decreased from 1.4 mg/dL to 0.7 mg/dL."
        },
        {
            "procedure_name": "CT of the Chest",
            "date": "Day 2 of hospitalization",
            "findings": {
                "description": "Bilateral ground-glass opacities, bilateral small effusions, right hilar and subcarinal lymphadenopathy."
            },
            "changes_over_time": "Repeat CT revealed worsening ground-glass opacities into areas of dense consolidation and worsening bilateral effusions by day 14."
        }
    ]
}